Serum microRNA-499 and microRNA-208a as biomarkers of acute myocardial infarction

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 1, 2014, Pages 136-141

  Xiao, Junjie ^a   Shen, Bo ^b   Li, Jin ^a   Lv, Dongcao ^a   Zhao, Yingying ^c   Wang, Fei ^c   Xu, Jiahong ^c  

^a SHANGHAI UNIVERSITY   (China)

^b SHANGHAI ENTRY EXIT INSPECTION AND QUARANTINE BUREAU   (China)

^c TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Acute myocardial infarction; Biomarker; MicroRNA; Serum

Indexed keywords

BIOCHEMICAL MARKER; MICRORNA; MICRORNA 208A; MICRORNA 499; UNCLASSIFIED DRUG;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; ECHOCARDIOGRAPHY; GENE EXPRESSION; MALE; MORBIDITY; MORTALITY; MOUSE; NONHUMAN; REAL TIME POLYMERASE CHAIN REACTION;

EID: 84892597665     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Fiedler J and Thum T. MicroRNAs in myocardial infarction. Arterioscler Thromb Vasc Bio 2013; 33: 201-205.
2. Xu J, Zhao J, Evan G, Xiao C, Cheng Y and Xiao J. Circulating microRNAs: novel biomarkers for cardiovascular diseases. J Mol Med (Berl) 2012; 90: 865-875.
3. Cheng Y, Tan N, Yang J, Liu X, Cao X, He P, Dong X, Qin S and Zhang C. A translational study of circulating cell-free microRNA-1 in acute myocardial infarction. Clinical Science (Lond) 2010; 119: 87-95.
4. Cortez MA, Bueso-Ramos C, Ferdin J, Lopez-Berestein G, Sood AK and Calin GA. MicroRNAs in body fluids--the mix of hormones and biomarkers. Nat Rev Clin Oncol 2011; 8: 467-477.
5. Kozomara A and Griffiths-Jones S. miRBase: integrating microRNA annotation and deep-sequencing data. Nucleic Acids Res 2011; 39: D152-157.
6. Kim GH. MicroRNA regulation of cardiac conduction and arrhythmias. Transl Res 2013; 161: 381-392.
7. Frankel LB and Lund AH. MicroRNA regulation of autophagy. Carcinogenesis 2012; 33: 2018-2025.
8. Xiao J, Liang D, Zhang H, Liu Y, Zhang D, Pan L, Chen X, Doevendans PA, Sun Y, Liang X, Sluijter JP and Chen YH. MicroRNA-204 is required for differentiation of human-derived cardiomyocyte progenitor cells. J Mol Cell Cardiol 2012; 53: 751-759.
9. Bauersachs J and Thum T. Biogenesis and regulation of cardiovascular microRNAs. Circ Res 2011; 109: 334-347.
10. Xiao J, Liang D, Zhang Y, Liu Y, Zhang H, Li L, Liang X, Sun Y and Chen YH. MicroRNA expression signature in atrial fibrillation with mitral stenosis. Physiol Genomics 2011; 43: 655-664.
11. Ciesla M, Skrzypek K, Kozakowska M, Loboda A, Jozkowicz A and Dulak J. MicroRNAs as biomarkers of disease onset. Anal Bioanal Chem 2011; 401: 2051-2061.
12. Fichtlscherer S, Zeiher AM and Dimmeler S. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Bio 2011; 31: 2383-2390.
13. Reid G, Kirschner MB and van Zandwijk N. Circulating microRNAs: Association with disease and potential use as biomarkers. Crit Rev Oncol Hematol 2011; 80: 193-208.
14. Fan KL, Zhang HF, Shen J, Zhang Q and Li XL. Circulating microRNAs levels in Chinese heart failure patients caused by dilated cardiomyopathy. Indian Heart J 2013; 65: 12-16.
15. Xiao J, Jing ZC, Ellinor PT, Liang D, Zhang H, Liu Y, Chen X, Pan L, Lyon R, Peng LY, Liang X, Sun Y, Popescu LM, Condorelli G and Chen YH. MicroRNA-134 as a potential plasma biomarker for the diagnosis of acute pulmonary embolism. J Transl Med 2011; 9: 159.
16. Ji X, Takahashi R, Hiura Y, Hirokawa G, Fukushima Y and Iwai N. Plasma miR-208 as a Biomarker of Myocardial Injury. Clin Chem 2009; 55: 1944-1949.
17. Adachi T, Nakanishi M, Otsuka Y, Nishimura K, Hirokawa G, Goto Y, Nonogi H and Iwai N. Plasma MicroRNA 499 as a Biomarker of Acute Myocardial Infarction. Clin Chem 2010; 56: 1183-1185.
18. Ai J, Zhang R, Li Y, Pu J, Lu Y, Jiao J, Li K, Yu B, Li Z, Wang R, Wang L, Li Q, Wang N, Shan H, Li Z and Yang B. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction. Biochem Biophys Res Commun 2010; 391: 73-77.
19. Corsten MF, Dennert R, Jochems S, Kuznetsova T, Devaux Y, Hofstra L, Wagner DR, Staessen JA, Heymans S and Schroen B. Circulating MicroRNA-208b and MicroRNA-499 reflect myocardial damage in cardiovascular disease. Circ Cardiovasc Genet 2010; 3: 499-506.
20. D'Alessandra Y, Devanna P, Limana F, Straino S, Di Carlo A, Brambilla PG, Rubino M, Carena MC, Spazzafumo L, De Simone M, Micheli B, Biglioli P, Achilli F, Martelli F, Maggiolini S, Marenzi G, Pompilio G and Capogrossi MC. Circulating microRNAs are new and sensitive biomarkers of myocardial infarction. Eur Heart J 2010; 31: 2765-2773.
21. Mayr M, Zampetaki A, Willeit P, Willeit J and Kiechl S. MicroRNAs Within the Continuum of Postgenomics Biomarker Discovery. Arterioscler Thromb Vasc Bio 2013; 33: 206-214.
22. Creemers EE, Tijsen AJ and Pinto YM. Circulating microRNAs: novel biomarkers and extracellular communicators in cardiovascular disease? Cir Res 2012; 110: 483-495.
23. Grasedieck S, Sorrentino A, Langer C, Buske C, Dohner H, Mertens D and Kuchenbauer F. Circulating microRNAs in hematological diseases: principles, challenges and perspectives. Blood 2013; 121: 4977-4984.
24. Zampetaki A, Willeit P, Tilling L, Drozdov I, Prokopi M, Renard JM, Mayr A, Weger S, Schett G, Shah A, Boulanger CM, Willeit J, Chowienczyk PJ, Kiechl S and Mayr M. Prospective study on circulating MicroRNAs and risk of myocardial infarction. J Am Coll Cardio 2012; 60: 290-299.
25. Widera C, Gupta SK, Lorenzen JM, Bang C, Bauersachs J, Bethmann K, Kempf T, Wollert KC and Thum T. Diagnostic and prognostic impact of six circulating microRNAs in acute coronary syndrome. J Mol Celll Cardiol 2011; 51: 872-875.
26. Egea V, Schober A and Weber C. Circulating miRNAs: messengers on the move in cardiovascular disease. Thromb Haemost 2012; 108: 590-591.
27. Oerlemans MI, Mosterd A, Dekker MS, de Very EA, van Mil A, Pasterkamp G, Doevendans PA, Hoes AW and Sluijter JP. Early assessment of acute coronary syndromes in the emergency department: the potential diagnostic value of circulating microRNAs. EMBO Mol Med 2012; 4: 1176-1185.
28. Dimmeler S and Zeiher AM. Circulating microRNAs: novel biomarkers for cardiovascular diseases? Eur Heart J 2010; 31: 2705-2707.
29. Long G, Wang F, Duan Q, Yang S, Chen F, Gong W, Yang X, Wang Y, Chen C and Wang DW. Circulating miR-30a, miR-195 and let-7b associated with acute myocardial infarction. PLoS One 2012; 7: e50926.
30. Falk E, Nakano M, Bentzon JF, Finn AV and Virmani R. Update on acute coronary syndromes: the pathologists' view. Eur Heart J 2013; 34: 719-728.
31. Cheng Y, Wang X, Yang J, Duan X, Yao Y, Shi X, Chen Z, Fan Z, Liu X, Qin S, Tang X and Zhang C. A translational study of urine miRNAs in acute myocardial infarction. J Mol Cell Cardiol 2012; 53: 668-676.
32. Wang GK, Zhu JQ, Zhang JT, Li Q, Li Y, He J, Qin YW and Jing Q. Circulating microRNA: a novel potential biomarker for early diagnosis of acute myocardial infarction in humans. Eur Heart J 2010; 31: 659-666.
33. De Rosa S, Fichtlscherer S, Lehmann R, Assmus B, Dimmeler S and Zeiher AM. Transcoronary concentration gradients of circulating microRNAs. Circulation 2011; 124: 1936-1944.
34. Olivieri F, Antonicelli R, Lorenzi M, D'Alessandra Y, Lazzarini R, Santini G, Spazzafumo L, Lisa R, La Sala L, Galeazzi R, Recchioni R, Testa R, Pompilio G, Capogrossi MC and Procopio AD. Diagnostic potential of circulating miR-499-5p in elderly patients with acute non ST-elevation myocardial infarction. Int J Cardiol 2013; 167: 531-536.
35. Diehl P, Fricke A, Sander L, Stamm J, Bassler N, Htun N, Ziemann M, Helbing T, El-Osta A, Jowett JB and Peter K. Microparticles: major transport vehicles for distinct microRNAs in circulation. Cardiovasc Res 2012; 93: 633-644.
36. van Empel VP, De Windt LJ and da Costa Martins PA. Circulating miRNAs: reflecting or affecting cardiovascular disease? Curr Hypertens Rep 2012; 14: 498-509.